You have access
Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells
QING TANG, MASAYOSHI ONITSUKA, ATSUSHI TABATA, TOSHIFUMI TOMOYASU and HIDEAKI NAGAMUNE
Anticancer Research July 2018, 38 (7) 4319-4325; DOI: https://doi.org/10.21873/anticanres.12731